The transferrin receptor has been identified as a key marker and mediator of iron-metabolism-related changes in HCC and was linked with worse prognosis after hepatectomy for HCC, probably secondary to the increased cellular invasion capacity of cells expressing it [112,113]. Here, TFRC is linked to hepatocellular carcinoma.